Precision medicine has changed what precision marketing has to look like. A generic HCP list or a static DTC segment might get a campaign out the door, but neither one goes beyond the surface. Two HCPs writing for the same drugs and diagnosing the same diseases can look identical on paper; that doesn't mean they're equally relevant to your brand, or that they should be reached the same way. The agencies winning pharma business right now are the ones digging deeper, building audiences shaped by data, methodology, and insight no other partner has access to.
That's what Helix for Audiences is designed to do.
Proprietary insights, not off-the-shelf segments
Most audience providers sell the same lists to everyone in the category. Helix works differently. Inside the platform, agencies get a query library built for audience creation, drawing on data most brands can't reach on their own: adherence patterns, diagnosing and prescribing behavior, specialty, and any first-party data an agency wants to bring into the mix.
That combination is what lets an agency start building audiences tied specifically to a brand's clinical story and commercial goals.
A methodology built for healthcare, not adapted to it
Writing a query is easy. Making sure that query holds up under HIPAA and state-level privacy rules is where many approaches fall apart. Helix bakes the DeepIntent patented audience methodology directly into the platform, so agencies aren't stitching together compliance after the fact. It's already there, at the click of a button.
In practice, that means HCP and DTC audiences can be built, compared, and shared quickly instead of over weeks, without a legal review holding up every iteration.
From audience to activation, without the handoff gap
A precise audience only pays off if it stays precise once it leaves the planning stage. Helix maps every audience to DeepIntent's identity graph, which gives it real connectivity across both programmatic channels and walled gardens: the two environments where targeting often falls apart in translation.
That means an agency can move from strategy to audience to activation in a few clicks, exporting straight into the DeepIntent DSP or social channels. No rebuilding the segment for each destination, and no drop-off in engagement quality once it gets there.
Why this matters for agencies
Every agency claims differentiation, but in a market where most providers can access overlapping data sources, that claim comes down to what you actually do with the data. A string of queries isn't a strategy. Helix gives agencies the data, the compliant methodology, and the activation path to turn that data into audiences that reach the right people and improve health and business outcomes.
That's the shift from executing someone else's plan to owning the strategy behind it.
This is part three of a five-part series on DeepIntent Helix. Next up: Helix for Activation, on turning those audiences into omnichannel campaigns. Learn more about Helix for Commercial Insights and Helix for Strategy & Planning.
